Metabolic follow-up at one year and beyond of women with gestational diabetes treated with insulin and/or oral hypoglycaemic agents: study protocol for the identification of a core outcomes set using a Delphi survey
Loading...
Files
Published Version
Date
2019-01-05
Authors
Bogdanet, Delia
Egan, Aoife M.
Fhelelboom, Narjes
Biesty, Linda M.
Thangaratinam, Shakila
Dempsey, Eugene M.
Crowther, Caroline
Devane, Declan
Dunne, Fidelma P.
Journal Title
Journal ISSN
Volume Title
Publisher
Springer Nature
Published Version
Abstract
Gestational diabetes (GDM) is associated with an increased lifetime risk for the development of glucose abnormalities, metabolic syndrome, cardiovascular disease, depression and tumours. Despite this high risk of additional comorbidities, there is no standardised approach to the long-term follow-up of women with a previous diagnosis of GDM. Also, there is no standardisation of outcome selection and reporting in studies involving this population. This increases the risk of reporting bias and reduces the possibility of meaningful comparisons between studies. The aim of this study is to develop a protocol for a core outcome set (COS) for the metabolic follow-up at 1 year and beyond of women with previous GDM treated with insulin and/or oral hypoglycaemic agents.
Description
Keywords
Core outcome set , Gestational diabetes , Insulin , Oral hypoglycaemic agents
Citation
Bogdanet, D., Egan, A., Fhelelboom, N., Biesty, L., Thangaratinam, S., Dempsey, E., Crowther, C., Devane, D. and Dunne, F., 2019. Metabolic follow-up at one year and beyond of women with gestational diabetes treated with insulin and/or oral hypoglycaemic agents: study protocol for the identification of a core outcomes set using a Delphi survey. Trials, 20(1).(7pp) DOI: 10.1186/s13063-018-3059-8